...
首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7‐Year Longitudinal Study
【24h】

Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7‐Year Longitudinal Study

机译:相对骨骼肌肿块与非酒精性脂肪肝病的关系:7年纵向研究

获取原文
获取原文并翻译 | 示例
           

摘要

Nonalcoholic fatty liver disease (NAFLD) has been associated with relative skeletal muscle mass in several cross‐sectional studies. We explored the effects of relative skeletal muscle mass and changes in relative muscle mass over time on the development of incident NAFLD or the resolution of baseline NAFLD in a large, longitudinal, population‐based 7‐year cohort study. We included 12,624 subjects without baseline NAFLD and 2943 subjects with baseline NAFLD who underwent health check‐up examinations. A total of 10,534 subjects without baseline NAFLD and 2631 subjects with baseline NAFLD were included in analysis of changes in relative skeletal muscle mass over a year. Subjects were defined as having NAFLD by the hepatic steatosis index, a previously validated NAFLD prediction model. Relative skeletal muscle mass was presented using the skeletal muscle mass index (SMI), a measure of body weight–adjusted appendicular skeletal muscle mass, which was estimated by bioelectrical impedance analysis. Of the 12,624 subjects without baseline NAFLD, 1864 (14.8%) developed NAFLD during the 7‐year follow‐up period. Using Cox proportional hazard analysis, compared with the lowest sex‐specific SMI tertile at baseline, the highest tertile was inversely associated with incident NAFLD (adjusted hazard ratio [AHR] = 0.44, 95% confidence interval [CI] = 0.38‐0.51) and positively associated with the resolution of baseline NAFLD (AHR = 2.09, 95% CI = 1.02‐4.28). Furthermore, compared with the lowest tertile of change in SMI over a year, the highest tertile exhibited a significant beneficial association with incident NAFLD (AHR = 0.69, 95% CI = 0.59‐0.82) and resolution of baseline NAFLD (AHR = 4.17, 95% CI = 1.90‐6.17) even after adjustment for baseline SMI. Conclusion: Increases in relative skeletal muscle mass over time may lead to benefits either in the development of NAFLD or the resolution of existing NAFLD.
机译:非酒精性脂肪肝疾病(NAFLD)与若干横截面研究中的相对骨骼肌肿块有关。我们探讨了相对骨骼肌肿块的影​​响和相对肌肉肿大的变化随着时间的推移在大型,纵向,基于人口7年的群组研究中的事故NAFLD或基线NAFLD的分辨率。我们包括12,624名受试者,没有基线NAFLD和2943名受试者,患有卫生检查考试的基线NAFLD。总共10,534名没有基线NAFLD的受试者和2631名受试者的基线NAFLD分析了一年多的相对骨骼肌肿块变化的分析。受试者被肝硬化指数的NAFLD定义为先前验证的NAFLD预测模型。使用骨骼肌质量指数(SMI)来提出相对骨骼肌肿块,衡量体重调整的附奇骨骼肌质量的量度,这通过生物电阻抗分析估算。在没有基线NAFLD的12,624名受试者中,1864年(14.8%)在7年的随访期间发达了NAFLD。使用Cox比例危害分析,与基线的最低性别特异性SMI Tertile相比,最高的Tertile与入射NAFLD相反(调整后的危险比[AHR] = 0.44,95%置信区间[CI] = 0.38-0.51)和与基线NAFLD的分辨率正相关(AHR = 2.09,95%CI = 1.02-4.28)。此外,与一年多的SMI变化的最低变化相比,最高的Tertile与事件NAFLD的显着有益关联(AHR = 0.69,95%CI = 0.59-0.82)和基线NAFLD的分辨率(AHR = 4.17,95 %CI = 1.90-6.17)即使在基线SMI调整后。结论:随着时间的推移,相对骨骼肌的增加可能导致NAFLD的发育或现有NAFLD的分辨率产生益处。

著录项

  • 来源
  • 作者单位

    Division of Endocrinology and Metabolism Department of Medicine Samsung Medical;

    Division of Endocrinology and Metabolism Department of Medicine Samsung Medical;

    Division of Endocrinology and Metabolism Department of Medicine Samsung Medical;

    Division of Endocrinology and Metabolism Department of Medicine Samsung Medical;

    Division of Endocrinology and Metabolism Department of Medicine Samsung Medical;

    Division of Endocrinology and Metabolism Department of Medicine Samsung Changwon;

    Division of Endocrinology and Metabolism Department of Medicine Samsung Medical;

    Division of Endocrinology and Metabolism Department of Medicine Samsung Medical;

    Department of Health Promotion Center Samsung Medical CenterSungkyunkwan University School of;

    Division of Endocrinology and Metabolism Department of Medicine Samsung Medical;

    Division of Endocrinology and Metabolism Department of Medicine Samsung Medical;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 消化系及腹部疾病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号